BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Prokarium

Prokarium logo

Founded
2012
Geography
United Kingdom based
Funding
$20.962 M

Prokarium is a privately owned, UK-based biotechnology company with a vision to create targeted vaccines and immunotherapies based on engineered Salmonella strains.


Posts Mentioning This Company

R&D Platform

-


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet